FN2 Earnings Intelligence
Universal Health Services, Inc. income statement
Universal Health Services, Inc. (UHS) Income Statement (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $115.3 | $102.8 | $119.4 | $126 | $137.8 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $12,642.1 | $13,399.4 | $14,282 | $15,827.9 | $17,364.8 | $18,597.2 | $19,496.6 |
| % Growth | 9.4% | 6.0% | 6.6% | 10.8% | 9.7% | 7.1% | 4.8% |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | $1,896.3 | $1,585.4 | $1,743.4 | $2,266.6 | $2,612.8 | - | - |
| % Margin | 15.0% | 11.8% | 12.2% | 14.3% | 15.0% | - | - |
| Net Income | $991.6 | $675.6 | $717.8 | $1,142.1 | $1,488.8 | - | - |
| % Margin | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% | - | - |
| Diluted EPS | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 | $22.77 | $24.55 |
| % Growth | 7.6% | -22.7% | 11.9% | 64.4% | 37.3% | -1.4% | 7.8% |
| Operating Cash Flow | $883.7 | $996 | $1,267.8 | $2,067.1 | $1,864.4 | - | - |
| CapEx | $855.7 | $734 | $743.1 | $943.8 | $1,015.2 | - | - |
| Free Cash Flow | $28 | $262 | $524.7 | $1,123.3 | $849.2 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $12,642.1 | $13,399.4 | $14,282 | $15,827.9 | $17,364.8 | $18,597.2 | $19,496.6 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | $1,896.3 | $1,585.4 | $1,743.4 | $2,266.6 | $2,612.8 | - | - |
| Net Income | $991.6 | $675.6 | $717.8 | $1,142.1 | $1,488.8 | - | - |
| Diluted EPS | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 | $22.77 | $24.55 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $115.3 | $102.8 | $119.4 | $126 | $137.8 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $4,141.9 | $4,726.5 | $4,785.8 | $4,464.5 | $4,004.4 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $883.7 | $996 | $1,267.8 | $2,067.1 | $1,864.4 |
| Capital Expenditure | $855.7 | $734 | $743.1 | $943.8 | $1,015.2 |
| Free Cash Flow | $28 | $262 | $524.7 | $1,123.3 | $849.2 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 9.4% | 6.0% | 6.6% | 10.8% | 9.7% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 15.0% | 11.8% | 12.2% | 14.3% | 15.0% |
| Net Margin | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| FCF Margin | 0.2% | 2.0% | 3.7% | 7.1% | 4.9% |
| Diluted EPS Growth | 7.6% | -22.7% | 11.9% | 64.4% | 37.3% |